Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Infect. 2012 Sep 12;66(4):303–312. doi: 10.1016/j.jinf.2012.09.005

Table 2.

Characteristics of patients with pulmonary tuberculosis in Orizaba, Veracruz, Mexico, 1995-2010.

Characteristic n/Total * (%) Non-smokers Light smokers Heavy
smokers
P value
§
P value
§ §
n/Total (%) n/Total (%) n/Total (%)
Sociodemographic characteristics
Age (Years) (Mean, SD) 45.45 (17.61) 46.86 (18.71) 41.18 (15.91) 40.81 (11.87) <0.001# <0.001
Men 627/1062 (59.0) 397/802 (49.5) 167/195 (85.6) 63/65 (96.9) <0.001 <0.001
Any formal education 338/1061 (31.9) 417/802 (52.0) 118/195 (60.5) 48/65 (73.25) 0.037 0.06
Work outside the home 583/1062 (54.9) 417/802 (52.0) 118/195 (60.5) 48/65 (73.25) <0.001 <0.001
Access to Social Security 373/1062 (35.1) 288/802 (35.9) 66/195 (33.8) 19/65 (29.2) 0.5 0.4
Alcohol consumption 475/1062 (44.7) 259/802 (32.3) 159/195 (81.5) 57/65 (87.7) <0.001 <0.001
Illegal drug use 58/1062 (5.5) 8/802 (1.0) 28/195 (14.4) 22/65 (33.8) <0.001 <0.001
Homelessness or imprisonment 37/1060 (3.5) 19/800 (2.4) 13/195 (6.7) 5/65 (7.7) 0.002 0.001
Distance to nearest health center (meters),
(Median, IQR**)
705 (422-1053) 726 (430-1127) 635 (398-972) 644 (374-900) 0.8 †† 0.007
Rural residence 137/1062 (12.9) 115/802 (14.3) 18/195 (9.2) 4/65 (6.2) 0.040 0.024
Household with earthen floor 234/1023 (22.9) 191/768 (24.9) 36/191 (18.8) 7/64 (10.9) 0.013 0.017
Crowding 336/1023 (32.84) 246/769 (32.0) 66/190 (34.7) 24/64 (37.5) 0.5 0.2
Clinical characteristics
Body Mass Index < 18 241/1061 (22.7) 178/801 (22.2) 44/195 (22.6) 19/65 (29.2) 0.4 0.4
HIV Infection 21/1036 (2.0) 13/782 (1.7) 5/192 (2.6) 3/62 (4.8) 0.2 0.1
Diabetes 348/1062 (32.8) 281/802 (35.0) 51/195 (26.2) 16/65 (24.6) 0.021 0.1
More than 10 bacilli per oil immersion field 281/1062 (26.5) 203/802 (25.3) 50/195 (25.6) 28/65 (43.1) 0.007 0.1
New patient upon enrollment 929/1062 (87.5) 692/802 (86.3) 178/195 (91.3) 59/65 (90.8) 0.1 0.6
Hemoptysis 362/1058 (34.2) 252/799 (31.5) 82/194 (42.3) 28/65 (43.1) 0.006 0.038
Fever 300/777 (38.6) 207/577(35.8) 67/151 (44.37) 26/49 (53.1) 0.016 0.004
Weight loss 906/1039 (87.2) 682/782 (87.2) 165/192 (85.9) 59/65 (90.8) 0.6 0.9
Cavitations 391/930 (42.0) 307/707 (43.4) 58/166 (34.9) 26/57 (45.6) 0.1 0.5
Night sweating 754/1060 (71.1) 556/801 (69.4) 146/194 (75.3) 52/65 (80.0) 0.1 0.4
Time elapsed between onset of symptoms
and treatment (days), (Median, IQR**)
107(65-186) 110(67-193) 94 (55-168) 135 (77-180) 0.034 †† 0.4
Mycobacteriology
Drug test
Sensitive 147/919 (16.0) 108/688 (15.7) 25/170 (14.7) 14/61 (23.0) 0.4
Resistance other than joint resistance to
isoniazid and rifampin
729/919 (79.3) 546/688 (79.4) 139/170 (81.8) 44/61 (72.1) 0.5 0.8
Joint resistance to isoniazid and rifampin 43/919 (4.7) 34/688 (4.9) 6/170 (3.5) 3/61 (4.9) 0.6
IS6110 cluster 175/946 (18.5) 135/712 (19.0) 29/171 (17.0) 11/63 (17.5) 0.8 0.6
*

Because there were missing values for the characteristics of some of the tuberculosis patients, several of the numbers below do not sum to the group total.

Light smokers: Individuals smoking 1-10 cigarettes per day.

Heavy smokers: Individuals smoking >10 cigarettes per dya.

§

Chi-square test with R × C contingency tables

§ §

Chi-square test for trends

D: Standard deviation.

#

Kruskal-Wallis test

**

IQR: Inter-quartile range.

††

One way ANOVA.